189 related articles for article (PubMed ID: 26446946)
21. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
Burkly LC; Michaelson JS; Zheng TS
Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
[TBL] [Abstract][Full Text] [Related]
23. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K
Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771
[TBL] [Abstract][Full Text] [Related]
24. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
25. A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.
Benicchi T; Iozzi S; Svahn A; Axelsson H; Mori E; Bernocco S; Cappelli F; Caramelli C; Fanti P; Genesio E; Maccari L; Markova N; Micco I; Porcari V; Schultz J; Fecke W
J Biomol Screen; 2012 Aug; 17(7):933-45. PubMed ID: 22644269
[TBL] [Abstract][Full Text] [Related]
26. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
28. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
[TBL] [Abstract][Full Text] [Related]
30. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
31. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
[TBL] [Abstract][Full Text] [Related]
32. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
[TBL] [Abstract][Full Text] [Related]
33. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
35. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
[TBL] [Abstract][Full Text] [Related]
36. Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies.
Nakayama M; Harada N; Okumura K; Yagita H
Biochem Biophys Res Commun; 2003 Jul; 306(4):819-25. PubMed ID: 12821115
[TBL] [Abstract][Full Text] [Related]
37. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
38. [Effect of dexamethasone on expressions of TWEAK and Fn14 in the lung of asthmatic mice].
Jun-Hong L; Luo YL; Lai WY; Wang WY; Gong J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1138-41. PubMed ID: 23127400
[TBL] [Abstract][Full Text] [Related]
39. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
40. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]